PubMed

Standardised metrics for global surgical surveillance.

Weiser TG, Makary MA, Haynes AB, Dziekan G, Berry WR, Gawande AA; Safe Surgery Saves Lives Measurement and Study Groups.

Lancet. 2009 Sep 26;374(9695):1113-7.PMID: 19782877 [PubMed - indexed for MEDLINE]Related articles

Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection.

Abbett SK, Yokoe DS, Lipsitz SR, Bader AM, Berry WR, Tamplin EM, Gawande AA.

Infect Control Hosp Epidemiol. 2009 Nov;30(11):1062-9.PMID: 19751156 [PubMed - in process]Related articles

The Better Colectomy Project: Association of Evidence-Based Best-Practice Adherence Rates to Outcomes in Colorectal Surgery.

Arriaga AF, Lancaster RT, Berry WR, Regenbogen SE, Lipsitz SR, Kaafarani HM, Elbardissi AW, Desai P, Ferzoco SJ, Bleday R, Breen E, Kastrinakis WV, Rubin MS, Gawande AA.

Ann Surg. 2009 Sep 2. [Epub ahead of print]PMID: 19734778 [PubMed - as supplied by publisher]Related articles

Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy.

Sonpavde G, Periman PO, Bernold D, Weckstein D, Fleming MT, Galsky MD, Berry WR, Zhan F, Boehm KA, Asmar L, Hutson TE.

Ann Oncol. 2009 Jul 24. [Epub ahead of print]PMID: 19633050 [PubMed - as supplied by publisher]Related articles

A surgical safety checklist to reduce morbidity and mortality in a global population.

Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, Herbosa T, Joseph S, Kibatala PL, Lapitan MC, Merry AF, Moorthy K, Reznick RK, Taylor B, Gawande AA; Safe Surgery Saves Lives Study Group.

N Engl J Med. 2009 Jan 29;360(5):491-9. Epub 2009 Jan 14.PMID: 19144931 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II trial of sunitinib for the therapy of progressive metastatic castration-refractory prostate cancer after previous docetaxel chemotherapy.

Sonpavde G, Hutson TE, Berry WR, Boehm KA, Asmar L.

Clin Genitourin Cancer. 2008 Sep;6(2):134-7.PMID: 18824440 [PubMed - indexed for MEDLINE]Related articles

An estimation of the global volume of surgery: a modelling strategy based on available data.

Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA.

Lancet. 2008 Jul 12;372(9633):139-44. Epub 2008 Jun 24.PMID: 18582931 [PubMed - indexed for MEDLINE]Related articles

Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapy.

Sonpavde G, Aparicio A, Guttierez I, Boehm KA, Hutson TE, Berry WR, Asmar L, von Hoff DD.

Clin Genitourin Cancer. 2007 Dec;5(7):457-9.PMID: 18272030 [PubMed - indexed for MEDLINE]Related articles

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data.

Fizazi K, Le Maitre A, Hudes G, Berry WR, Kelly WK, Eymard JC, Logothetis CJ, Pignon JP, Michiels S; Meta-analysis of Estramustine in Prostate Cancer (MECaP) Trialists' Collaborative Group.

Lancet Oncol. 2007 Nov;8(11):994-1000. Epub 2007 Oct 17.PMID: 17942366 [PubMed - indexed for MEDLINE]Related articles

Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.

Sonpavde G, Chi KN, Powles T, Sweeney CJ, Hahn N, Hutson TE, Galsky MD, Berry WR, Kadmon D.

Cancer. 2007 Dec 15;110(12):2628-39. Review.PMID: 17941029 [PubMed - indexed for MEDLINE]Related articlesFree article

Problems with the randomized discontinuation design.

Sonpavde G, Hutson TE, Galsky MD, Berry WR.

J Clin Oncol. 2006 Oct 1;24(28):4669-70; author reply 4670-1. No abstract available. PMID: 17008711 [PubMed - indexed for MEDLINE]Related articles

Systemic chemotherapy for urothelial cancer.

Sonpavde G, Hutson TE, Berry WR.

Clin Genitourin Cancer. 2006 Jun;5(1):34-42. Review.PMID: 16859577 [PubMed - indexed for MEDLINE]Related articles

Systemic therapy for prostate cancer.

Berry WR.

N C Med J. 2006 Mar-Apr;67(2):154-7. Review. No abstract available. PMID: 16752722 [PubMed - indexed for MEDLINE]Related articles

Hormone refractory prostate cancer: Management and advances.

Sonpavde G, Hutson TE, Berry WR.

Cancer Treat Rev. 2006 Apr;32(2):90-100. Epub 2006 Feb 3. Review.PMID: 16458434 [PubMed - indexed for MEDLINE]Related articles

Re-induction of hormonal sensitivity in hormone-refractory prostate cancer--fact or fiction?

Berry WR.

Nat Clin Pract Oncol. 2005 Apr;2(4):180-1. No abstract available. PMID: 16264926 [PubMed - indexed for MEDLINE]Related articles

The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer.

Berry WR.

Urology. 2005 Jun;65(6 Suppl):2-7. Review.PMID: 15939076 [PubMed - indexed for MEDLINE]Related articles

Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancer.

Berry WR, Hathorn JW, Dakhil SR, Loesch DM, Jackson DV, Gregurich MA, Newcomb-Fernandez JK, Asmar L.

Clin Prostate Cancer. 2004 Sep;3(2):104-11.PMID: 15479494 [PubMed - indexed for MEDLINE]Related articles

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA; TAX 327 Investigators.

N Engl J Med. 2004 Oct 7;351(15):1502-12.PMID: 15470213 [PubMed - indexed for MEDLINE]Related articlesFree article

Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study.

Gregory SA, Case DC Jr, Bosserman L, Litwak DL, Berry WR, Kalman LA, Belt RJ, Saven A.

Clin Lymphoma. 2003 Sep;4(2):93-8.PMID: 14556680 [PubMed - indexed for MEDLINE]Related articles

Mediastinal bronchogenic cyst manifesting as a catastrophic myocardial infarction.

Kennebeck GA, Wong AK, Berry WR, Higgins JP, Manubens SM.

Ann Thorac Surg. 1999 Jun;67(6):1789-91.PMID: 10391298 [PubMed - indexed for MEDLINE]Related articles